Status:
UNKNOWN
Early and Late Prognosis in Patients With Guillain-Barre Syndrome
Lead Sponsor:
First Affiliated Hospital of Wenzhou Medical University
Conditions:
Guillain-Barre Syndrome
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The goal of this observational study is to explore significant indicators to predict the early prognosis and late prognosis in patients with Guillain-Barre syndrome.
Detailed Description
This is a multicenter study(approximately three) with over 450 subjects.Clinical data were collected by consulting the patient's electronic history. The data included demographic information, blood bi...
Eligibility Criteria
Inclusion
- patients fulfilled clinical, biological, and electrophysiology criteria for Guillain-barre syndrome.
Exclusion
- nonidiopathic Guillain-barre syndrome and Miller Fisher syndrome
Key Trial Info
Start Date :
January 2 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2025
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT06041451
Start Date
January 2 2013
End Date
January 31 2025
Last Update
September 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China, 325000